choline has been researched along with Rupture, Spontaneous in 2 studies
Rupture, Spontaneous: Tear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koay, YC | 1 |
| Chen, YC | 1 |
| Wali, JA | 1 |
| Luk, AWS | 1 |
| Li, M | 1 |
| Doma, H | 1 |
| Reimark, R | 1 |
| Zaldivia, MTK | 1 |
| Habtom, HT | 1 |
| Franks, AE | 1 |
| Fusco-Allison, G | 1 |
| Yang, J | 1 |
| Holmes, A | 1 |
| Simpson, SJ | 1 |
| Peter, K | 1 |
| O'Sullivan, JF | 1 |
| Vöö, S | 1 |
| Kwee, RM | 1 |
| Sluimer, JC | 1 |
| Schreuder, FH | 1 |
| Wierts, R | 1 |
| Bauwens, M | 1 |
| Heeneman, S | 1 |
| Cleutjens, JP | 1 |
| van Oostenbrugge, RJ | 1 |
| Daemen, JW | 1 |
| Daemen, MJ | 1 |
| Mottaghy, FM | 1 |
| Kooi, ME | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-MRI in Carotid Artery Atherosclerosis Patients[NCT02640313] | Phase 3 | 14 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for choline and Rupture, Spontaneous
| Article | Year |
|---|---|
Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
Topics: Animal Feed; Animals; Atherosclerosis; Bacteria; Biomarkers; Carotid Artery Diseases; Choline; Coron | 2021 |
Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Asymptomatic Diseases; Biomarkers; Ca | 2016 |